Soluble ST2 does not change cardiovascular risk prediction compared to cardiac troponin T in kidney transplant candidates

BACKGROUND: Solubility of Tumorigenicity 2 (sST2) is a novel biomarker that better stratifies risk of cardiovascular events (CVE) compared to cardiac troponin T(cTnT) in heart failure. We assessed the association of sST2 with the composite outcome of CVE and/or mortality compared to cTnT in kidney t...

Descripción completa

Detalles Bibliográficos
Autores principales: Keddis, Mira T., El-Zoghby, Ziad, Kaplan, Bruce, Meeusen, Jeffrey W., Donato, Leslie J., Cosio, Fernando G., Steidley, D. Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509308/
https://www.ncbi.nlm.nih.gov/pubmed/28704488
http://dx.doi.org/10.1371/journal.pone.0181123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509308/
https://www.ncbi.nlm.nih.gov/pubmed/28704488
http://dx.doi.org/10.1371/journal.pone.0181123

Ejemplares similares